Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity

Area of Science:

• Ototoxicity research
• Pharmacology
• Audiology

Background:

• Acquired hearing loss from hospital-prescribed medications impacts 1 million people yearly in Western Europe and North America.
• Current treatments lack approved drugs to prevent or treat hearing loss induced by platinum-based anticancer drugs or aminoglycoside antibiotics.
• Drug-induced hearing loss significantly affects quality of life, particularly in pediatric and geriatric populations.

Purpose of the Study:

• To review and synthesize current knowledge on the mechanisms of acquired hearing loss caused by medications.
• To identify knowledge gaps concerning iatrogenic causes of hearing loss.
• To emphasize the urgent need for research into preventative and therapeutic strategies.

Main Methods:

• Comprehensive literature review of studies on drug-induced ototoxicity.
• Analysis of mechanisms underlying hearing loss from platinum-based chemotherapy and aminoglycoside antibiotics.
• Identification of research gaps in clinical practice and therapeutic development.

Main Results:

• Detailed understanding of the pathophysiological pathways leading to drug-induced hearing loss.
• Highlighting the lack of effective pharmaceutical interventions for ototoxicity.
• Identification of specific knowledge deficits requiring further investigation.

Conclusions:

• Further research is essential to refine clinical practices for managing drug-induced hearing loss.
• Development of novel therapeutic agents is urgently required to prevent or treat this condition.
• Addressing iatrogenic hearing loss is critical for improving patient outcomes and quality of life.